- Home
- IMNM vs LMNR Comparison
IMNM vs LMNR Comparison
Compare IMNM & LMNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- LMNR
- Stock Information
- Founded
- IMNM 2006
- LMNR 1893
- Country
- IMNM United States
- LMNR United States
- Employees
- IMNM N/A
- LMNR N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- LMNR Farming/Seeds/Milling
- Sector
- IMNM Health Care
- LMNR Consumer Staples
- Exchange
- IMNM Nasdaq
- LMNR Nasdaq
- Market Cap
- IMNM 542.6M
- LMNR 440.5M
- IPO Year
- IMNM 2020
- LMNR N/A
- Fundamental
- Price
- IMNM $7.91
- LMNR $16.02
- Analyst Decision
- IMNM Strong Buy
- LMNR Hold
- Analyst Count
- IMNM 6
- LMNR 1
- Target Price
- IMNM $26.00
- LMNR $23.00
- AVG Volume (30 Days)
- IMNM 1.7M
- LMNR 76.9K
- Earning Date
- IMNM 05-13-2025
- LMNR 06-05-2025
- Dividend Yield
- IMNM N/A
- LMNR 1.88%
- EPS Growth
- IMNM N/A
- LMNR N/A
- EPS
- IMNM N/A
- LMNR 0.43
- Revenue
- IMNM $9,041,000.00
- LMNR $186,077,000.00
- Revenue This Year
- IMNM N/A
- LMNR N/A
- Revenue Next Year
- IMNM $1,259.12
- LMNR $11.90
- P/E Ratio
- IMNM N/A
- LMNR $37.49
- Revenue Growth
- IMNM N/A
- LMNR 2.39
- 52 Week Low
- IMNM $5.15
- LMNR $15.58
- 52 Week High
- IMNM $19.07
- LMNR $29.22
- Technical
- Relative Strength Index (RSI)
- IMNM 55.28
- LMNR 31.61
- Support Level
- IMNM $6.96
- LMNR $15.76
- Resistance Level
- IMNM $7.56
- LMNR $16.90
- Average True Range (ATR)
- IMNM 0.69
- LMNR 0.78
- MACD
- IMNM 0.26
- LMNR 0.06
- Stochastic Oscillator
- IMNM 98.22
- LMNR 16.67
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About LMNR Limoneira Co
Limoneira Co is an agribusiness company. The company's operating segments include Fresh Lemons; Lemon Packing; Avocados and Other Agribusiness. It generates maximum revenue from the Fresh Lemons segment.